Frist W H, Gerhardt E B, Merrill W H, Atkinson J B, Eastburn T E, Stewart J R, Hammon J W, Bender H W
Department of Cardiac and Thoracic Surgery, Vanderbilt University Medical Center, Nashville, Tenn.
J Heart Transplant. 1990 Nov-Dec;9(6):724-6.
The treatment for recurrent cardiac allograft rejection refractory to conventional immunotherapy is retransplantation. When retransplantation is not possible, alternative approaches must be undertaken. This report reviews the successful management of persistently recurring rejection using five serial 14-day courses of OKT3 in a 35-year-old man after two heart transplantations.
对于常规免疫疗法难治的复发性心脏移植排斥反应,治疗方法是再次移植。当无法进行再次移植时,必须采取其他方法。本报告回顾了一名35岁男性在两次心脏移植后,使用五个连续14天疗程的OKT3成功治疗持续性复发性排斥反应的情况。